Stress caused by unfolded and misfolded proteins in the endoplasmic reticulum (so called "ER stress") intersects with metabolic disease at multiple levels
NANOMEDICINE
Thyroid cancer management is evolving to reflect novel developments in imaging, cytology, molecular biology and the outcome of trials evaluating low versus high dose radioiodine therapy
Muscle is recognised as important endocrine organ and target for the treatment of metabolic syndrome. This symposium will explore the breadth of our new understanding of basic metabolism and investigative clinical data that is currently emerging.
Two million people in the UK are living with or beyond cancer. Many are at risk of endocrinopathy
Therapeutic management of adults with CAH
Amiodarone
Preventing and managing long term complications of acromegaly
Novel drugs targeting steroid synthesis and metabolism provide new avenues for treating human diseases
As humans have migrated towards the poles, a number of changes have occurred to our endocrine systems which have allowed us to adapt to our new environment, particularly daily and seasonal changes in light intensity and duration. In this symposium we will explore those endocrine systems most affected by latitudinal light levels and our adaptations to overcome these changes
THIS HOUSE BELIEVES THAT ALL ADRENAL PATIENTS WITH INCIDENTALOMA WHO FAIL TO SUPPRESS CORTISOL AFTER DEXAMETHASONE SHOULD HAVE AN ADRENALECTOMY
Therapeutic management of adults with CAH
MicroRNAs have emerged in recent years as key regulators in cancer and endocrine disease. They dramatically modify gene expression at the post-transcriptional stage
Amiodarone
Management of persistent TSH elevation in hypothyroid patients
The surgical approaches to MEN1 - what the endocrinologist needs to know
It’s not what I eat, it’s what my mother ate. Can maternal lifestyle or nutrition programme life-long metabolic and endocrine problems in their offspring.
CURRENT CONCEPTS AND MANAGEMENT OF PHAEOCHROMOCYTOMA
THYROID EYE DISEASE
Recent breakthroughs from the genetics of mineralocorticoid hypertension
Emerging knowledge of the molecular mechanisms in medullary carcinoma of the thyroid is improving our understanding of this condition, which is now impacting on therapy
ADDISON'S/PHAEOCHROMOCYTOMAS/CONN'S SYNDROME
Optogenetics: controlling cells with light
All you need to know about CHIP-sequencing
Prioritising therapy in neuroendocrine tumours
Regulating periods and optimising fertility in PCOS
Developing growth hormone agonists and antagonists for the clinic
Long-term outcome and quality of life in patients with disorders of sex development
What the endocrinologist needs to know
Real world approaches to clinical dilemmas
The surgical approaches to MEN1 - what the endocrinologist needs to know
Management of persistent TSH elevation in hypothyroid patients
Preventing and managing long term complications of acromegaly
Regulating periods and optimising fertility in PCOS
Stress caused by unfolded and misfolded proteins in the endoplasmic reticulum (so called "ER stress") intersects with metabolic disease at multiple levels
NANOMEDICINE
Thyroid cancer management is evolving to reflect novel developments in imaging, cytology, molecular biology and the outcome of trials evaluating low versus high dose radioiodine therapy
Muscle is recognised as important endocrine organ and target for the treatment of metabolic syndrome. This symposium will explore the breadth of our new understanding of basic metabolism and investigative clinical data that is currently emerging.
Two million people in the UK are living with or beyond cancer. Many are at risk of endocrinopathy
Therapeutic management of adults with CAH
Amiodarone
Preventing and managing long term complications of acromegaly
Novel drugs targeting steroid synthesis and metabolism provide new avenues for treating human diseases
As humans have migrated towards the poles, a number of changes have occurred to our endocrine systems which have allowed us to adapt to our new environment, particularly daily and seasonal changes in light intensity and duration. In this symposium we will explore those endocrine systems most affected by latitudinal light levels and our adaptations to overcome these changes
THIS HOUSE BELIEVES THAT ALL ADRENAL PATIENTS WITH INCIDENTALOMA WHO FAIL TO SUPPRESS CORTISOL AFTER DEXAMETHASONE SHOULD HAVE AN ADRENALECTOMY
Therapeutic management of adults with CAH
MicroRNAs have emerged in recent years as key regulators in cancer and endocrine disease. They dramatically modify gene expression at the post-transcriptional stage
Amiodarone
Management of persistent TSH elevation in hypothyroid patients
The surgical approaches to MEN1 - what the endocrinologist needs to know
It’s not what I eat, it’s what my mother ate. Can maternal lifestyle or nutrition programme life-long metabolic and endocrine problems in their offspring.
CURRENT CONCEPTS AND MANAGEMENT OF PHAEOCHROMOCYTOMA
THYROID EYE DISEASE
Recent breakthroughs from the genetics of mineralocorticoid hypertension
Emerging knowledge of the molecular mechanisms in medullary carcinoma of the thyroid is improving our understanding of this condition, which is now impacting on therapy
ADDISON'S/PHAEOCHROMOCYTOMAS/CONN'S SYNDROME
Optogenetics: controlling cells with light
All you need to know about CHIP-sequencing
Prioritising therapy in neuroendocrine tumours
Regulating periods and optimising fertility in PCOS
Developing growth hormone agonists and antagonists for the clinic
Long-term outcome and quality of life in patients with disorders of sex development
What the endocrinologist needs to know
Real world approaches to clinical dilemmas
The surgical approaches to MEN1 - what the endocrinologist needs to know
Management of persistent TSH elevation in hypothyroid patients
Preventing and managing long term complications of acromegaly
Regulating periods and optimising fertility in PCOS
0 result(s) found.